These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15634033)

  • 21. Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.
    de Maat MM; Huitema AD; Mulder JW; Meenhorst PL; van Gorp EC; Beijnen JH
    Br J Clin Pharmacol; 2002 Oct; 54(4):378-85. PubMed ID: 12392585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients.
    Kappelhoff BS; Huitema AD; Crommentuyn KM; Mulder JW; Meenhorst PL; van Gorp EC; Mairuhu AT; Beijnen JH
    Br J Clin Pharmacol; 2005 Feb; 59(2):174-82. PubMed ID: 15676039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
    Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection.
    Colombo S; Buclin T; Cavassini M; Décosterd LA; Telenti A; Biollaz J; Csajka C
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3801-8. PubMed ID: 16940065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term pharmacokinetics of amprenavir in combination with delavirdine in HIV-infected children.
    Engelhorn C; Hoffmann F; Kurowski M; Stocker H; Kruse G; Notheis G; Belohradsky BH; Wintergerst U
    AIDS; 2004 Jul; 18(10):1473-5. PubMed ID: 15199327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection.
    Morse GD; Fischl MA; Shelton MJ; Cox SR; Thompson L; Della-Coletta AA; Freimuth WW
    Clin Drug Investig; 2003; 23(4):255-61. PubMed ID: 17535038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of fluconazole in people with HIV infection: a population analysis.
    McLachlan AJ; Tett SE
    Br J Clin Pharmacol; 1996 Apr; 41(4):291-8. PubMed ID: 8730974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients.
    Solas C; Gagnieu MC; Ravaux I; Drogoul MP; Lafeuillade A; Mokhtari S; Lacarelle B; Simon N
    Ther Drug Monit; 2008 Dec; 30(6):670-3. PubMed ID: 18806695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus.
    Csajka C; Marzolini C; Fattinger K; Décosterd LA; Telenti A; Biollaz J; Buclin T
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3226-32. PubMed ID: 15328077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test.
    Cheng CL; Smith DE; Carver PL; Cox SR; Watkins PB; Blake DS; Kauffman CA; Meyer KM; Amidon GL; Stetson PL
    Clin Pharmacol Ther; 1997 May; 61(5):531-43. PubMed ID: 9164415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.
    Kappelhoff BS; Huitema AD; Sankatsing SU; Meenhorst PL; Van Gorp EC; Mulder JW; Prins JM; Beijnen JH
    Br J Clin Pharmacol; 2005 Sep; 60(3):276-86. PubMed ID: 16120066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans.
    Nanzigu S; Eriksen J; Makumbi F; Lanke S; Mahindi M; Kiguba R; Beck O; Ma Q; Morse GD; Gustafsson LL; Waako P
    HIV Med; 2012 Apr; 13(4):193-201. PubMed ID: 22107359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of abacavir in infants, toddlers and children.
    Zhao W; Piana C; Danhof M; Burger D; Della Pasqua O; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2013 Jun; 75(6):1525-35. PubMed ID: 23126277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of apparent clearance of valproic acid in adult Saudi patients.
    Alqahtani S; Alandas N; Alsultan A
    Int J Clin Pharm; 2019 Aug; 41(4):1056-1061. PubMed ID: 31222537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.
    Courlet P; Guidi M; Glatard A; Alves Saldanha S; Cavassini M; Buclin T; Marzolini C; Eap CB; Decosterd LA; Csajka C;
    Br J Clin Pharmacol; 2019 Sep; 85(9):2022-2032. PubMed ID: 31144347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of nevirapine in Malaysian HIV patients: a non-parametric approach.
    Mustafa S; Yusuf WN; Woillard JB; Choon TS; Hassan NB
    Eur J Clin Pharmacol; 2016 Jul; 72(7):831-8. PubMed ID: 27025609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.
    López-Cortés LF; Ruiz-Valderas R; Viciana P; Alarcón-González A; Gómez-Mateos J; León-Jimenez E; Sarasanacenta M; López-Pua Y; Pachón J
    Clin Pharmacokinet; 2002; 41(9):681-90. PubMed ID: 12126459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART.
    Panhard X; Goujard C; Legrand M; Taburet AM; Diquet B; Mentré F;
    Br J Clin Pharmacol; 2005 Oct; 60(4):390-403. PubMed ID: 16187971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.